{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:44:58Z","timestamp":1792784698477,"version":"4.5.0"},"reference-count":34,"publisher":"American Chemical Society (ACS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001791","name":"Griffith University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001791","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Griffith Institute for Biomedicine & Glycomics","id":[{"id":"https:\/\/ror.org\/02hsggv49","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In this study, we conducted the first chemical investigation of the Australian bryozoan Amathia tricornis, leading to the isolation and characterization of 11 new metabolites, including the bromoindoles tricornamines A\u2212E (1\u22125), phenethylamine amathamines E\u2212F (6\u22127), and guanadino-containing phenethylamides tricornamides A\u2212D (8\u221211), together with three known compounds; amathamides E\u2212F (12\u221213) and lamourimidazolinium trifluoroacetate (14). We also report the binding affinity of 6, 7, 9 and 10 to the Parkinson\u2019s disease implicated protein \u03b1-synuclein. This has provided new insight into the structure\u2212activity relationships of brominated phenethylamino metabolites towards this neurodegenerative disease-relevant target. The new natural products expand the chemical diversity reported from Amathia species and further support bryozoans as a promising source of unique compounds.<\/jats:p>","DOI":"10.1021\/acs.jnatprod.6c00883","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:25:52Z","timestamp":1788452752000},"page":"2706-2717","source":"Crossref","is-referenced-by-count":0,"title":["\u03b1-Synuclein Binding Alkaloids from the Australian Bryozoan\n                    <i>Amathia tricornis<\/i>"],"prefix":"10.1021","volume":"89","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1527-1084","authenticated-orcid":true,"given":"Francesca","family":"Ferretti","sequence":"first","affiliation":[{"name":"Griffith University (Gold Coast Campus) , , Parklands Drive , , ,","place":["Southport, Queensland, Australia, 4222"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua B.","family":"Hayton","sequence":"additional","affiliation":[{"name":"Griffith University (Gold Coast Campus) , , Parklands Drive , , ,","place":["Southport, Queensland, Australia, 4222"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7211-4651","authenticated-orcid":true,"given":"George D.","family":"Mellick","sequence":"additional","affiliation":[{"name":"Griffith University (Gold Coast Campus) , , Parklands Drive , , ,","place":["Southport, Queensland, Australia, 4222"]},{"name":"Griffith University , , Don Young Road , , ,","place":["Nathan, Queensland, Australia, 4111"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7695-8301","authenticated-orcid":true,"given":"Anthony R.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Griffith University (Gold Coast Campus) , , Parklands Drive , , ,","place":["Southport, Queensland, Australia, 4222"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"2026100909070224800_cit1","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","article-title":"The Amyloid State of Proteins in Human Diseases","volume":"148","author":"Eisenberg","year":"2012","journal-title":"Cell"},{"key":"2026100909070224800_cit2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2174\/138920309789351921","article-title":"Biophysics of Parkinson\u2019s disease: structure and aggregation of alpha-synuclein","volume":"10","author":"Uversky","year":"2009","journal-title":"Curr. Protein Pept. Sci."},{"key":"2026100909070224800_cit3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/s0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"2026100909070224800_cit4","doi-asserted-by":"publisher","first-page":"862","DOI":"10.12688\/f1000research.25634.1","article-title":"Recent developments in the treatment of Parkinson\u2019s disease","volume":"9","author":"Stoker","year":"2020","journal-title":"F1000Research"},{"key":"2026100909070224800_cit5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3389\/fnins.2018.00693","article-title":"Emerging treatment approaches for Parkinson\u2019s disease","volume":"12","author":"Stoker","year":"2018","journal-title":"Front. Neurosci."},{"key":"2026100909070224800_cit6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/oxfordjournals.qjmed.a067623","article-title":"The Impact of Treatment with Levodopa on Parkinson\u2019s Disease","volume":"49","author":"Shaw","year":"1980","journal-title":"Q. J. Med."},{"key":"2026100909070224800_cit7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.20517\/2347-8659.2020.58","article-title":"A review on Parkinson\u2019s disease treatment","volume":"8","author":"Lee","year":"2021","journal-title":"Neuroimmunol. Neuroinflammation"},{"key":"2026100909070224800_cit8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3389\/fnmol.2019.00299","article-title":"Targeting alpha-synuclein as a therapy for Parkinson\u2019s disease","volume":"12","author":"Fields","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"2026100909070224800_cit9","doi-asserted-by":"publisher","DOI":"10.1002\/bip.23117","article-title":"Molecular determinants of the interaction of EGCG with ordered and disordered proteins","volume":"109","author":"Fusco","year":"2018","journal-title":"Biopolymers"},{"key":"2026100909070224800_cit10","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/s1099-4831(05)61002-4","article-title":"The marine bromotyrosine derivatives","volume":"61","author":"Peng","year":"2005","journal-title":"Alkaloids Chem Biol."},{"key":"2026100909070224800_cit11","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3390\/md18040200","article-title":"The phylum Bryozoa: From biology to biomedical potential","volume":"18","author":"Ciavatta","year":"2020","journal-title":"Mar. Drugs"},{"key":"2026100909070224800_cit12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1039\/b617546e","article-title":"Bryozoan metabolites: an ecological perspective","volume":"24","author":"Sharp","year":"2007","journal-title":"Nat. Prod. Rep."},{"key":"2026100909070224800_cit13","doi-asserted-by":"publisher","first-page":"6846","DOI":"10.1021\/ja00388a092","article-title":"Isolation and structure of bryostatin 1","volume":"104","author":"Pettit","year":"1982","journal-title":"J. Am. Chem. Soc."},{"key":"2026100909070224800_cit14","doi-asserted-by":"publisher","first-page":"11141","DOI":"10.1073\/pnas.0403921101","article-title":"Therapeutic effects of PKC activators in Alzheimer\u2019s disease transgenic mice","volume":"101","author":"Etcheberrigaray","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026100909070224800_cit15","doi-asserted-by":"publisher","first-page":"7879","DOI":"10.1016\/j.tet.2015.08.017","article-title":"Kororamide B, a brominated alkaloid from the bryozoan Amathia tortuosa and its effects on Parkinson\u2019s disease cells","volume":"71","author":"Dashti","year":"2015","journal-title":"Tetrahedron"},{"key":"2026100909070224800_cit16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1039\/c0ob00538j","article-title":"Wilsoniamines A and B: Novel alkaloids from the temperate Australian bryozoan, Amathia wilsoni","volume":"9","author":"Carroll","year":"2011","journal-title":"Org. Biomol. Chem."},{"key":"2026100909070224800_cit17","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1016\/j.tetlet.2012.03.126","article-title":"Kororamide A, a new tribrominated indole alkaloid from the Australian bryozoan Amathia tortuosa","volume":"53","author":"Carroll","year":"2012","journal-title":"Tetrahedron Lett."},{"key":"2026100909070224800_cit18","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1021\/acs.jnatprod.0c00929","article-title":"Antiplasmodial Alkaloids from the Australian Bryozoan Amathia lamourouxi","volume":"83","author":"Kleks","year":"2020","journal-title":"J. Nat. Prod."},{"key":"2026100909070224800_cit19","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1016\/j.bmc.2011.06.006","article-title":"Convolutamines I and J, antitrypanosomal alkaloids from the bryozoan Amathia tortusa","volume":"19","author":"Davis","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"2026100909070224800_cit20","doi-asserted-by":"publisher","first-page":"151047","DOI":"10.1016\/j.tetlet.2019.151047","article-title":"Two new betaines from the Australian bryozoan Amathia lamourouxi","volume":"60","author":"Voser","year":"2019","journal-title":"Tetrahedron Lett."},{"key":"2026100909070224800_cit21","doi-asserted-by":"publisher","first-page":"3860","DOI":"10.1039\/c004360e","article-title":"Synthesis of 4-functionalized-1H-indoles from 2,3-dihalophenols","volume":"8","author":"Sanz","year":"2010","journal-title":"Org. Biomol. Chem."},{"key":"2026100909070224800_cit22","unstructured":"National Institute of Advanced Industrial Science and Technology Spectral Database for Organic Compounds (SDBS): 2,4,6-tribromoanisole, SDBS No. 51807, CAS RN 607-99-8. https:\/\/sdbs.db.aist.go.jp\/CompoundLanding.aspx?sdbsno=51807 (accessed June 04 2026)."},{"key":"2026100909070224800_cit23","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1016\/j.tet.2015.04.091","article-title":"Synthesis of marine brominated alkaloid amathamide F: a palladium-catalyzed enamide synthesis","volume":"71","author":"Ahmad","year":"2015","journal-title":"Tetrahedron"},{"key":"2026100909070224800_cit24","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1071\/ch9871655","article-title":"Further amathamide alkaloids from the bryozoan Amathia wilsoni","volume":"40","author":"Blackman","year":"1987","journal-title":"Aust. J. Chem."},{"key":"2026100909070224800_cit25","unstructured":"Royal Society of Chemistry\n          . MarinLit. https:\/\/marinlit.rsc.org (accessed May 19 2026)."},{"key":"2026100909070224800_cit26","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/jhet.3641","article-title":"Synthesis and Applications of 2-Substituted Imidazole and Its Derivatives: A Review","volume":"56","author":"Daraji","year":"2019","journal-title":"J. Heterocycl. Chem."},{"key":"2026100909070224800_cit27","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1021\/np970042+","article-title":"Alternatamides A\u2212 D: New Bromotryptamine Peptide Antibiotics from the Atlantic Marine Bryozoan Amathia alternata","volume":"60","author":"Lee","year":"1997","journal-title":"J. Nat. Prod."},{"key":"2026100909070224800_cit28","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1021\/ol0627348","article-title":"Total Synthesis of Flustramine C via Dimethylallyl Rearrangement","volume":"9","author":"Lindel","year":"2007","journal-title":"Org. Lett."},{"key":"2026100909070224800_cit29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1039\/d3np00037k","article-title":"The shikimate pathway: gateway to metabolic diversity","volume":"41","author":"Shende","year":"2024","journal-title":"Nat. Prod. Rep."},{"key":"2026100909070224800_cit30","doi-asserted-by":"publisher","first-page":"20230352","DOI":"10.1098\/rstb.2023.0352","article-title":"Evolution of aromatic amino acid metabolism in plants: a key driving force behind plant chemical diversity in aromatic natural products","volume":"379","author":"Yokoyama","year":"2024","journal-title":"Philos. Trans. R. Soc., B"},{"key":"2026100909070224800_cit31","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1021\/acschemneuro.9b00092","article-title":"Identification of a New \u03b1-Synuclein Aggregation Inhibitor via Mass Spectrometry Based Screening","volume":"10","author":"Xu","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"2026100909070224800_cit32","doi-asserted-by":"publisher","first-page":"100472","DOI":"10.1016\/j.rechem.2022.100472","article-title":"\u03b1-synuclein aggregation inhibitory activity of the bromotyrosine derivatives aerothionin and aerophobin-2 from the subtropical marine sponge Aplysinella sp","volume":"4","author":"Prebble","year":"2022","journal-title":"Results Chem."},{"key":"2026100909070224800_cit33","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1071\/ch9891427","article-title":"Two new bromotyrosine-derived metabolites from an Australian marine sponge, Aplysina sp","volume":"42","author":"Xynas","year":"1989","journal-title":"Aust. J. Chem."},{"key":"2026100909070224800_cit34","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1021\/acs.jnatprod.1c01172","article-title":"\u03b1-Synuclein aggregation inhibitory prunolides and a dibrominated \u03b2-carboline sulfamate from the ascidian Synoicum prunum","volume":"85","author":"Holland","year":"2022","journal-title":"J. Nat. Prod."}],"container-title":["Journal of Natural Products"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jnatprod.6c00883","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jnprdf\/article-pdf\/89\/9\/2706\/68683084\/np6c00883.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jnprdf\/article-pdf\/89\/9\/2706\/68683084\/np6c00883.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T13:29:47Z","timestamp":1791552587000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jnprdf\/article\/89\/9\/2706\/5405429\/Synuclein-Binding-Alkaloids-from-the-Australian"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,2]]},"published-print":{"date-parts":[[2026,9,25]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jnatprod.6c00883","relation":{},"ISSN":["0163-3864","1520-6025"],"issn-type":[{"value":"0163-3864","type":"print"},{"value":"1520-6025","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]}}}